Neil Goldsmith Stepping Down as CEO and Board Member of Evolva

REINACH, Switzerland–(BUSINESS WIRE)– Evolva (SIX: EVE) today announces the departure of CEO Neil
Goldsmith and his succession by the current Chief Operating Officer
(COO), Simon Waddington.

Since co-founding Evolva, Neil Goldsmith has been instrumental in
Evolva’s development over the last thirteen years, moving the company
from a pharmaceutical oriented biotech start-up to a listed business
developing and selling specialty ingredients for health, wellness and
nutrition markets. Neil’s entrepreneurial approach has led to the launch
by Evolva of products such as nootkatone and resveratrol, and the
advancement of best-tasting stevia products to an anticipated launch in
2018, as communicated earlier this year.

Evolva’s Board and executive management have recently determined that
the near-term focus needs to be on growing the market opportunity for
Evolva’s products and delivering attractive margins. This more focused
approach is not a natural fit with Neil’s entrepreneurial strengths,
something recognized by both Neil and the Board. As a consequence Neil
and the Board have mutually agreed that Neil will step down as CEO and
member of the Evolva Board with immediate effect.

Neil will be succeeded by Simon Waddington, currently COO of Evolva.
Simon had previously been the CEO of Abunda Inc. until its acquisition
by Evolva in 2011 upon which he joined the management team. His
background and experience is ideally suited to the next phase of
Evolva’s evolution.

Gerard Hoetmer, Chairman of Evolva’s Board of Directors, said “On
behalf of the whole Board, I would like to thank Neil for all his
efforts to bring Evolva to where it is today. We are confident that
under Simon’s leadership the next steps in the transformation of Evolva
to a product-based business can be made. More information on the
transformation will be shared at the half-year results announcement on
August 14^th.”

About Evolva
Evolva solves the supply chain issues of nature
through a 21^st century mix of biotechnology and brewing. We
develop, make and sell natural ingredients that provide significant
benefits to people in daily life, but whose supply chain issues have
limited their use until now. Our flagship ingredients are stevia,
nootkatone and resveratrol, but we work on many more, both on our own
behalf and with others. To make our world sustainable requires nature
and technology to work together as one, and our aim is to play a (small)
part in achieving this transformation. We operate internationally. For
more information see www.evolva.com.
Questions about our approach? Have a look at our video.

This press release contains specific forward-looking statements, e.g.
statements including terms like believe, assume, expect or similar
expressions. Such forward-looking statements are subject to known and
unknown risks, uncertainties and other factors which may result in a
substantial divergence between the actual results, financial situation,
development or performance of the company and those explicitly or
implicitly presumed in these statements. Against the background of these
uncertainties readers should not place undue reliance on forward-looking
statements. The company assumes no responsibility to update
forward-looking statements or to adapt them to future events or
developments.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170706006165/en/